Skip to content

January 26, 2023

Private Capital Journal
Private Capital Journal
Primary Navigation Menu
Menu
  • Deals
    • Venture Capital Deals
    • Private Equity Deals
    • Angel Deals
    • Private Deals
    • Public Deals
    • M&A/Exit Deals
    • IPO, RTO Deals
    • Government Funding
  • Funds/Firms
    • VC Funds
    • PE Funds
    • Pension Funds
    • Government Funds
    • Family Offices
    • Retail FundsRetail Funds, MICs, Public Traded Funds, Private Debt/Royalty Fund
    • Publicly Traded Funds
    • Infra Funds
    • Real Estate Funds
    • Mutual Funds
    • Accelerator Funds
    • Angel Funds
    • Merchant Banks
    • Law Firms
    • Accounting Firms
  • People
    • VC Firms
    • PE Firms
    • Pension Funds
    • Retail Funds/VCCs
    • Law Firms
    • Angel Groups
    • Investment Firms
    • Financial Advisors
    • Service Providers
    • EMDs
    • Portfolio
    • PCMA
  • Region
    • British Columbia
    • Alberta
    • Saskatchewan
    • Manitoba
    • Ontario
    • Quebec
    • New Brunswick
    • Nova Scotia
    • Prince Edward Island
    • Newfoundland and Labrador
    • Northwest Territories
    • Yukon
    • Nunavut
    • United States
    • Europe
    • Africa
    • Americas
    • Asia Pacific
    • Middle East
  • Sectors
    • IT and Telecom
    • Biotech and Life Sciences
    • HealthCare
    • CleanTech
    • Oil and Gas
    • Mining
    • Aerospace and Defence
    • Agri-Food
    • Business Products and Services
    • Consumer Products and Services
    • Education
    • Financial
    • Forestry
    • Industrial and Manufacturing
    • Media and Entertainment
    • Power and Utilities
    • Real Estate
    • Transportation and Logistics
  • Analysis
    • Analysis
    • Editorial
    • Deal of the Week
    • CPE Media Leaderboard
  • About Us
  • Advertise
  • Contact

Biotech and Life Sciences

Shockwave Medical to acquire Neovasc for up to US $147M

2023-01-17
On: January 17, 2023
In: British Columbia, Biotech and Life Sciences, M&A/Exit Deals, United States

Shockwave Medical, Inc. (NASDAQ: SWAV) to acquire Neovasc Inc. (NASDAQ/TSX: NVCN) for US $27.25 per share for US $100M upfront in cash, plus up to US $12 per share in deferred payment for up to US $47M. Continue Reading

Onc.AI Secures US $25M Series A led by MassMutual and Action Potential

2023-01-05
On: January 5, 2023
In: Venture Capital Deals, Biotech and Life Sciences, Ontario, United States

Akshay Nanduri and Salmaan Ahmed’s Onc.AI has raised US $25M in Series A funding led by MassMutual and Action Potential Venture Capital (a GSK venture fund) with participation of Life Extension Ventures, Blue Venture Fund, Accomplice, Digitalis Ventures, and KdT Ventures. Continue Reading

Venture backed Searchlight Pharma to acquire Miravo Healthcare for $91.4M

2022-12-26
On: December 26, 2022
In: Biotech and Life Sciences, M&A/Exit Deals, Ontario, Quebec

Fonds de solidarité FTQ and Crédit Mutuel Equity backed Searchlight Pharma to acquire Nuvo Pharmaceuticals Inc. dba Miravo Healthcare for $91.4M from Deerfield Management Company, Red Oak Partners, LLC, and other shareholders.Continue Reading

Perceiv AI secures $1.5M seed financing led by Plug & Play Ventures

2022-12-12
On: December 12, 2022
In: Venture Capital Deals, Biotech and Life Sciences, Quebec, IT and Telecom

Dr. Christian Dansereau and César Laurent’s Perceiv AI secured $1.M in seed funding led by Plug & Play Ventures with participation of Centre for Aging + Brain Health Innovation (CABHI), Boreal Ventures, IKJ Capital, Red Abbey Labs, Investissement Québec, private investors. Continue Reading

ABK Biomedical secures US $30M Series C

2022-12-09
On: December 9, 2022
In: Venture Capital Deals, Biotech and Life Sciences, Nova Scotia

ABK Biomedical secured US $30M Series C led by Santé Ventures and Medtronic with participation of existing investors F-Prime Capital, Eight Roads Ventures and others. Carissa Bellardine Black from Medtronic and James Eadie from Santé Ventures joined ABK board of directors. Continue Reading

Automate Medical secures seed financing

2022-12-07
On: December 7, 2022
In: Venture Capital Deals, Biotech and Life Sciences, Ontario, IT and Telecom

Andrew Arruda, Thomas Hamilton, and Joshua Kelly founded Automate Medical secured seed financing with Apollo Projects, Tribe Capital, Village Global, and Canadian and US private investors.
Continue Reading

Q BioMed acquires 15% of Mannin Research

2022-11-14
On: November 14, 2022
In: Venture Capital Deals, Biotech and Life Sciences, Ontario

Q BioMed Inc. converted its long-term royalty agreement with Mannin Research Inc., receiving 15% stakes, at CDN $30M valuation, and US $20M in royalty payment on realization of future net sales.Continue Reading

KA Imaging secures In-Q-Tel investment and Government of Canada funding

2022-11-02
On: November 2, 2022
In: Venture Capital Deals, Biotech and Life Sciences, Ontario, Government Funding

KA Imaging secured funding from INOVAIT through Government of Canada’s Strategic Innovation Fund, and strategic investment and technology development agreement with In-Q-Tel. Continue Reading

Sagard Healthcare Partners acquires revenue interest in Marinus’ ganaxolone

2022-10-31
On: October 31, 2022
In: Private Equity Deals, Biotech and Life Sciences, United States

Marinus Pharmaceuticals entered into a revenue interest financing agreement with Sagard Healthcare Partners for US $32.5M upfront in return for payments based on U.S. net sales of ganaxolone, including the recently approved ZTALMY® (ganaxolone) oral suspension CV. Continue Reading

enGene secures bridge financing

2022-10-28
On: October 28, 2022
In: Venture Capital Deals, Biotech and Life Sciences, Quebec

enGene secured new round of bridge financing led by Forbion Capital Partners with participation of Fonds de solidarité FTQ and Lumira funds.Continue Reading

Monteris Medical secures US $73M Series D and debt funding

2022-10-27
On: October 27, 2022
In: Venture Capital Deals, Biotech and Life Sciences, Manitoba, United States

Monteris Medical secured US $35M Series D led by InnovaHealth Partners with participation of Birchview Capital and US $28M debt facility provided by Madryn Asset Management, LP with option to draw an additional US $10M. Continue Reading

Inversago Pharma secures US $70M Series C led by NEA

2022-10-17
On: October 17, 2022
In: Venture Capital Deals, Biotech and Life Sciences, Quebec

Inversago Pharma secured US $70M Series C led by New Enterprise Associates (NEA) with participation of Forbion Growth Opportunities Fund, Amgen Ventures, and existing investors Forbion Capital Fund IV, Fonds de solidarité FTQ, Genesys Capital, AmorChem, JDRF T1D Fund and adMare BioInnovations. Continue Reading

TerrAscend secures US$45.5M debt financing from Pelorus Equity Group

2022-10-12
On: October 12, 2022
In: Biotech and Life Sciences, Public Deals, Ontario, United States

CSE listed TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) closed non-brokered senior secured term loan for US $45.5M from funds managed by Pelorus Equity Group. Continue Reading

Portland Investment Counsel invests US $40M in RadioMedix

2022-10-10
On: October 10, 2022
In: Venture Capital Deals, Biotech and Life Sciences, United States

RadioMedix secured US $40M Series A funding from Portland Investment Counsel Inc. Continue Reading

Blue-Zone Technologies secures $8M financing

2022-10-04
On: October 4, 2022
In: Venture Capital Deals, Biotech and Life Sciences, CleanTech, Ontario

Dusanka Filipovic founded and Kipton Lade led Blue-Zone Technologies secured $8M financing jointly led by Canadian Venture Capital arm of Crédit Mutuel Equity and Round Pound Ventures, LLC. David Bacon, CEO of Halocarbon Life Sciences, joined Blue-Zone board of directors. Continue Reading

SK Capital Partners to acquire Apotex Pharmaceutical Holdings

2022-10-01
On: October 1, 2022
In: Private Equity Deals, Biotech and Life Sciences, Ontario

SK Capital Partners to acquire Dr. Barry Sherman founded and Jeff Watson and Gordon Fahner led Apotex Pharmaceutical Holdings Inc. RBC Capital Markets, The Bank of Nova Scotia, HSBC and Truist Securities are providing committed debt financing. Continue Reading

GrowerIQ secures $3M seed financing led by Golden Section and MaRS IAF

2022-09-13
On: September 13, 2022
In: Venture Capital Deals, Biotech and Life Sciences, Ontario, IT and Telecom

Andrew Wilson led GrowerIQ secured $3M seed funding led by Golden Section and MaRS Investment Accelerator Fund (MaRS IAF) with participation from LAGO, Delbridge, GTM Fund and Gaingels.
Continue Reading

Posts navigation

1 2 … 35 Next

Subscribe to Our Daily Summary

Confirmation Required - check your junk folder should you NOT receive our confirmation email immediately. Real name, please. (We never spam, but if you feel that we have no business in knowing your real name, please don’t subscribe. Our privacy policy)

Please confirm your subscription. Unconfirmed subscriptions will be removed within 24 hours.


Private Capital Journal is a publication of CPE News, Canada’s leading all private capital and public financing news

Privacy and Terms

Privacy Policy
Terms of Use

© 2023 CPE News, a division of CPE Media & Data Company. All Rights Reserved. 500-245 Fairview Mall Drive, Toronto, Ontario M2J 4T1 | 647-872-6300